What is BDH Industries Ltd (MBIND) share price return in the past 10 years?

BDH Industries Ltd share price has appreciated 17.1% annually (CAGR) over the past ten years.

What is the share price of BDH Industries Ltd (MBIND)?

Company share prices are keep on changing according to the market conditions. The current trading price of BDH Industries Ltd (MBIND) on 04-Jun-2026 16:59:59 at 16:59 is 359.95.

What is the P/E ratio of BDH Industries?

The latest standalone P/E ratio of BDH Industries as of 04-Jun-2026 is 19.17.

What is the P/B ratio of BDH Industries Ltd (MBIND)?

The latest standalone P/B ratio of BDH Industries Ltd (MBIND) as of 04-Jun-2026 is 2.74.

What is the 52-week high and low of BDH Industries Ltd (MBIND)?

The 52-week high of BDH Industries Ltd (MBIND) is Rs. 523.75 and the 52-week low is Rs. 245.00.

BDH Industries Ltd (MBIND) Share Analysis – Quality, Pipeline & Valuation Zone & DeciZen Rating

Name: BDH Industries Ltd (MBIND)
Brand: BDH Industries

BDH Industries Ltd (MBIND)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524828 NSE: MBIND Pharmaceuticals & Drugs | Small Cap | BDH Inds Share Price

BDH Industries Ltd (MBIND)

Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524828 NSE: MBIND Pharmaceuticals & Drugs | Small Cap | BDH Inds Share Price

Key Metrics

Valuation Multiples

Market Cap

₹207 Cr.

Current Price

₹360

52-Week Low / High

₹245 / 524

TTM EPS

₹18.8

TTM Sales

₹96 Cr.

Book Value per Share

₹131.5

P/E Ratio

19.17

Higher than its 5-year historical median

Industry PE

46.5

Price to Book (P/B)

2.74

Higher than its 5-year historical median

Price to Sales (P/S)

2.16

Higher than its 5-year historical median

EV/EBITDA

11.16

Higher than its 5-year historical median

Dividend Yield

1.71%

Profitability Efficiency

Return on Equity (ROE)

14.46%

Outperforms industry median

Return on Capital Employed (ROCE)

18.18%

Outperforms industry median

Return on Assets (ROA)

10.28%

Operating Profit Margin

17.5%

Net Profit Margin

13.94%

Gross Profit Margin

20.1%

Growth Momentum
1-yr vs 3-yr growth

Sales Growth (1 Year)

Slowing versus 3-year growth rate

-22.51%

Operating Profit Growth (1 Year)

Slowing versus 3-year growth rate

-6.6%

Net Profit Growth (1 Year)

Slowing versus 3-year growth rate

-6.08%

Asset Quality

Promoter Holding

49.70%

Pledged shares (%) of Promoter's holding (%)

8.99%

Reserves

₹70 Cr.

Equity

₹5.8 Cr.

Face Value

₹10

All Time Low / High

₹2.45 / 523.75

BDH Industries stock performance

Key Ratios

Check Before You Invest

Quality

Locked

Valuation

Locked

Price Trend

Locked

Q.1 Is BDH Industries Ltd a good quality company?

BDH Industries Ltd is a good quality company, based on a consistently good multi-year financial track record.

This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.

We have analysed the performance of the company on the following:

How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.

How does BDH Industries Ltd performance compare with that of its Peers?

Q.1 Revenue growth of BDH Industries Ltd vs industry peers?

BDH Industries Ltd revenue CAGR is 2.26%, compared to the industry median CAGR of 5.35%, indicating slower growth and losing its market share.

Q.1 Promoter shareholding and pledge status of BDH Industries Ltd?

Promoters hold 49.70% of the BDH Industries Ltd, with 8.99% of their stake pledged, indicating low pledge risk.

Q.1 Stock return of BDH Industries Ltd over the last decade?

Over the last 9 year(s), the stock has delivered a CAGR of 17% based on the current price.

10 Year X-Ray : Login to view analysis.

Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Value Creation ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
ROCE % ⓘ	15.4%	14.9%	14.7%	16.9%	19.1%	18.7%	19.6%	20.8%	21%	18.2%	-
Value Creation Index ⓘ	0.1	0.1	0.1	0.2	0.4	0.3	0.4	0.5	0.5	0.3	-
Growth Parameters ⓘ
Sales ⓘ	46.1	43.7	41	51.7	59.5	57.5	69.4	74.5	85.8	66.5	96
Sales YoY Gr.	-	-5.3%	-6.1%	26%	15.1%	-3.4%	20.8%	7.3%	15.3%	-22.5%	-
Adj EPS ⓘ	5.6	5.8	6.5	8.4	10.3	11.1	12	14.3	17.1	16.1	18.8
YoY Gr.	-	3.9%	12.8%	28.3%	23%	7.1%	8.6%	18.8%	20.3%	-6%	-
BVPS (₹) ⓘ	44.6	48	51.6	56.9	63.7	72.2	82.1	92.7	105.7	117.1	131.5
Adj Net Profit ⓘ	3.2	3.3	3.8	4.8	5.9	6.4	6.9	8.2	9.9	9.3	11
Cash Flow from Ops. ⓘ	4.3	7.2	-0.2	-3.6	11.4	0.8	3	6.3	-1.9	14.8	-
Debt/CF from Ops. ⓘ	2.2	1.2	-51.5	-3.6	0.8	10.9	0.8	0.8	-4.7	0.1	-

CAGR ⓘ

	9 Years	5 Years	3 Years	1 Years
Sales ⓘ	4.2%	2.3%	-1.4%	-22.5%
Adj EPS ⓘ	12.5%	9.3%	10.3%	-6%
BVPSⓘ	11.3%	12.9%	12.6%	10.9%
Share Price	17.1%	29.3%	34.8%	40.6%

Key Financial Parameters ⓘ

	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25	TTM
Return on Equity % ⓘ	12.5	11.8	12.5	14.7	16.4	15.6	15.1	15.9	16.9	14.2	15.1
Op. Profit Mgn % ⓘ	8.9	11	13.1	13.6	15.1	14.8	13.1	14.7	14.5	17.5	14.5
Net Profit Mgn % ⓘ	7	7.6	9.2	9.3	10	11.1	10	11	11.5	13.9	11.3
Debt to Equity ⓘ	0.4	0.3	0.3	0.4	0.3	0.2	0.1	0.1	0.1	0	0
Working Cap Days ⓘ	126	111	132	155	146	156	154	160	175	229	144
Cash Conv. Cycle ⓘ	-18	-34	-44	-13	-4	-6	8	6	21	29	108

Profit And Loss

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Sales	46	44	41	52	59	57	69	74	86	67
Operating Expenses ⓘ +	42	39	36	45	51	49	60	64	73	55
Manufacturing Costs	8	7	7	9	9	7	8	10	8	8
Material Costs	24	23	20	27	31	33	44	44	55	37
Employee Cost	5	6	6	7	7	6	7	7	7	7
Other Costs ⓘ	4	3	2	3	3	3	2	3	2	3
Operating Profit ⓘ	4	5	5	7	9	9	9	11	12	12
Operating Profit Margin (%)	8.9%	11.0%	13.1%	13.5%	15.1%	14.8%	13.1%	14.7%	14.5%	17.5%
Other Income ⓘ +	2	1	1	1	1	1	1	1	2	2
Exceptional Items ⓘ	0	0	0	0	0	0	0	0	0	0
Interest ⓘ	0	0	0	1	1	0	0	0	0	0
Depreciation ⓘ	1	1	1	1	1	1	1	1	1	1
Profit Before Tax ⓘ	5	5	5	7	8	9	10	11	13	12
Tax ⓘ	2	2	1	2	2	2	2	3	3	3
Profit After Tax	3	3	4	5	6	6	7	8	10	9
PAT Margin (%)	7.0%	7.6%	9.2%	9.3%	10.0%	11.1%	10.4%	11.0%	11.5%	13.9%
Adjusted EPS (₹)	5.6	5.8	6.5	8.4	10.3	11.1	12.6	14.3	17.1	16.1
Dividend Payout Ratio (%)	35.70%	34.50%	34.40%	32.80%	24.20%	27.20%	28.70%	28.10%	26.30%	27.90%

Valuation of BDH Inds - Standalone

YTD 1Y 3Y 5Y 10Y Max

Analyst's Notes

No data found!

Balance Sheet

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Equity and Liabilities
Shareholders Fund +	27	29	31	34	38	43	49	55	62	69
Share Capital ⓘ	6	6	6	6	6	6	6	6	6	6
Reserves ⓘ	21	23	25	28	32	37	43	49	56	63
Debt +	9	8	8	13	9	9	2	5	9	1
Long Term Debt	0	1	0	0	0	0	0	0	0	0
Short Term Debt	9	8	7	13	9	9	2	5	9	1
Minority Interest	0	0	0	0	0	0	0	0	0	0
Trade Payables	13	14	16	16	16	17	16	19	21	15
Others Liabilities ⓘ	2	3	2	2	2	2	2	2	1	2
Total Liabilities ⓘ	52	54	57	66	65	71	69	80	93	87
Fixed Assets
Net Fixed Assets ⓘ +	13	23	23	22	21	20	20	19	20	20
Gross Block	25	35	36	36	36	36	36	36	38	38
Accumulated Depreciation	12	12	13	14	15	16	16	17	17	18
CWIP ⓘ	4	0	0	0	0	0	0	0	0	0
Investments ⓘ	0	0	0	0	0	0	0	0	0	0
Inventories	5	3	6	8	5	5	7	7	5	7
Trade Receivables	8	8	7	13	11	15	15	17	28	14
Cash Equivalents ⓘ	20	19	17	17	23	23	19	26	25	31
Others Assets ⓘ	2	1	4	6	5	7	9	11	14	14
Total Assets ⓘ	52	54	57	66	65	71	69	80	93	87

Cash Flow

(All Figures are in Crores.)

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Cash Flow From Operating Activity ⓘ +	4	7	-0	-4	11	1	3	6	-2	15
PBT ⓘ	5	5	5	7	8	9	10	11	13	12
Adjustment ⓘ	1	-0	0	0	1	-0	-0	-0	-1	-1
Changes in Working Capital ⓘ	0	4	-4	-9	5	-5	-3	-2	-11	6
Tax Paid ⓘ	-2	-2	-1	-2	-2	-2	-3	-3	-3	-3
Cash Flow From Investing Activity ⓘ +	-5	-5	0	1	1	1	1	0	-0	2
Capex	-5	-7	-0	-0	-0	-0	1	-0	-2	-0
Net Investments	0	0	0	0	0	0	0	-0	0	0
Others ⓘ	0	1	1	1	1	1	1	1	2	2
Cash Flow From Financing Activity ⓘ +	-1	-3	-3	3	-6	-2	-8	0	1	-10
Net Proceeds from Shares ⓘ	0	0	0	0	0	0	0	0	0	0
Net Proceeds from Borrowing ⓘ	0	1	-1	-0	0	0	0	0	0	0
Interest Paid ⓘ	0	-0	-0	-1	-1	-0	-0	-0	-0	-0
Dividend Paid ⓘ	-1	-1	-1	-1	-2	-1	-2	-2	-2	-3
Others ⓘ	1	-2	-0	5	-4	-1	-6	3	4	-8
Net Cash Flow ⓘ	-1	-1	-2	0	6	-0	-4	7	-1	6

Financial Ratio

PARTICULARS	Mar'16	Mar'17	Mar'18	Mar'19	Mar'20	Mar'21	Mar'22	Mar'23	Mar'24	Mar'25
Ratios
ROE (%)	13.4	12.51	13.13	15.46	17.11	16.26	16.27	16.31	17.28	14.46
ROCE (%)	15.39	14.9	14.74	16.94	19.14	18.74	19.61	20.84	21.03	18.18
Asset Turnover Ratio	0.9	0.84	0.74	0.84	0.91	0.84	0.99	1	0.99	0.74
PAT to CFO Conversion(x)	1.33	2.33	-0	-0.8	1.83	0.17	0.43	0.75	-0.2	1.67
Working Capital Days
Receivable Days	69.60	65.40	67.10	69.60	72.50	83.20	78.10	76.40	95.70	116.70
Inventory Days	40.60	32.10	40.60	49.40	39	33.20	31.90	34	25.90	34
Payable Days	212.60	219.20	271.30	221.40	186.60	183.10	140.90	147.80	131.80	178.50

Management X-Ray

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged ^*

0.00

8.99

* Pledged shares as % of Promoter's holding (%)

Top 5 Mutual Funds Holding

Last Visited Stocks

Announcements

BDH Industries Ltd FAQs

The current trading price of BDH Inds on 04-Jun-2026 16:59 is ₹359.9.

Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 03-Jun-2026 the market cap of BDH Inds stood at ₹207.2 Cr

The latest P/E ratio of BDH Inds as of 03-Jun-2026 is 19.17.

The latest P/B ratio of BDH Inds as of 03-Jun-2026 is 2.74.

The 52-week high of BDH Inds is ₹523.8 and the 52-week low is ₹245.0.

The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of BDH Inds is ₹95.95 ( Cr.) .

Past 10 year's financial track record analysis by Moneyworks4me indicates that BDH Industries Ltd is a good quality company.

The key valuation ratios of BDH Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of BDH Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

About BDH Industries Ltd

BDH Industries was incorporated on December 5, 1990 and was converted into a public limited company on April 29, 1994.

BDH Industries is engaged in the manufacture and marketing of formulations and bulk drugs. It is today recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals.

BDH exports a wide range of finished pharmaceutical formulations and bulk drugs to leading organizations in several countries, including Australia, Bolivia, Denmark, Dominican Republic, Germany, Ghana, Japan, Kenya, Madagascar, Malaysia, Mozambique, Netherlands, Niger, Nigeria, Papua New Guinea, Yemen, Singapore, Sri Lanka, Sudan, West Indies, Zambia, Zimbabwe, etc.

Products offered by the Company:

Some of its therapeutical categories are:

1. Anti-cancer 2. Antibiotics & Anti-microbials 3. Cardiovascular 4. Psychotropic 5. External Preparations 6. Sterile Opthalmics Preparations 7. Generics & Branded Generics 8. Injectables

It also manufactures sildenafil citrate tablets for male impotency

Achievements:

The Government of the India has accorded 'Star Export House' status to the company
The Government of India also accredited the company with WHO-GMP Certification since 1982.
It has received Federation of Indian Export Organisations (FIEO) Export Award 'Niryat Shree'
The company has received Chemexcil Top Export Award
It has also received Chemexcil Trishul Award for Consistent Export Performance
It has received the Government of Maharashtra's Export Award
Ministry of Commerce's Award from the President of India was conferred on the company.
2010
â€¢ BDH Industries won â€˜Good Corporate Citizenâ€™ Award by Bombay Chamber of Commerce & Industry 2010
â€¢ BDH Industries won State Pharmaceutical Corporation (SPC) Sri Lanka Merit Award 2010
â€¢ WHO-GMP Certificatation since 1982, renewed WHO-GMP in 2010

BDH Industries Ltd (MBIND)

BDH Industries Ltd (MBIND)

BDH Industries stock performance